Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Ciarrocchi

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Human Pathology|October 20, 2012
Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysisSimonetta Piana, Moira Ragazzi, Giovanni Tallini, et al.
Cells|March 11, 2023
An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer MetastatizationFederica Torricelli, Elisabetta Sauta, Veronica Manicardi, et al.
Cell Death Discovery|July 8, 2026
BET inhibition unmasks a targetable glycolytic dependency through a HIF1α stabilization and driven transcriptional program in a defined subset of triple-negative breast CancerTeresa Rossi, Egidio Iorio, Mattea Chirico, et al.
Melanoma Research|May 23, 2019
Exploring metabolic reprogramming in melanoma via acquired resistance to the oxidative phosphorylation inhibitor phenforminMariaelena Pistoni, Giulia Tondelli, Cristina Gallo, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive BiomarkersGiusi Bondì, Serafina Martella, Dimitrios Stylianakis, et al.
Endocrine Connections|July 3, 2019
Expression of NOTCH1 in thyroid cancer is mostly restricted to papillary carcinomaSimonetta Piana, Eleonora Zanetti, Alessandra Bisagni, et al.
The Journal of Clinical Endocrinology and Metabolism|July 24, 2012
Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomasValentina Sancisi, Gloria Borettini, Sally Maramotti, et al.
Molecular Cancer|July 17, 2023
Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapyF Torricelli, B Donati, F Reggiani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
An Epithelial-to-Mesenchymal Transcriptional Switch Triggers Evolution of Pulmonary Sarcomatoid Carcinoma (PSC) and Identifies Dasatinib as New Therapeutic OptionGloria Manzotti, Federica Torricelli, Donati Benedetta, et al.
Thyroid : Official Journal of the American Thyroid Association|January 29, 2015
Molecular testing of thyroid fine-needle aspirations improves presurgical diagnosis and supports the histologic identification of minimally invasive follicular thyroid carcinomasMarkus Eszlinger, Simonetta Piana, Anja Moll, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Human Pathology|October 20, 2012
Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysisSimonetta Piana, Moira Ragazzi, Giovanni Tallini, et al.
Cells|March 11, 2023
An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer MetastatizationFederica Torricelli, Elisabetta Sauta, Veronica Manicardi, et al.
Cell Death Discovery|July 8, 2026
BET inhibition unmasks a targetable glycolytic dependency through a HIF1α stabilization and driven transcriptional program in a defined subset of triple-negative breast CancerTeresa Rossi, Egidio Iorio, Mattea Chirico, et al.
Melanoma Research|May 23, 2019
Exploring metabolic reprogramming in melanoma via acquired resistance to the oxidative phosphorylation inhibitor phenforminMariaelena Pistoni, Giulia Tondelli, Cristina Gallo, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive BiomarkersGiusi Bondì, Serafina Martella, Dimitrios Stylianakis, et al.
Endocrine Connections|July 3, 2019
Expression of NOTCH1 in thyroid cancer is mostly restricted to papillary carcinomaSimonetta Piana, Eleonora Zanetti, Alessandra Bisagni, et al.
The Journal of Clinical Endocrinology and Metabolism|July 24, 2012
Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomasValentina Sancisi, Gloria Borettini, Sally Maramotti, et al.
Molecular Cancer|July 17, 2023
Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapyF Torricelli, B Donati, F Reggiani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
An Epithelial-to-Mesenchymal Transcriptional Switch Triggers Evolution of Pulmonary Sarcomatoid Carcinoma (PSC) and Identifies Dasatinib as New Therapeutic OptionGloria Manzotti, Federica Torricelli, Donati Benedetta, et al.
Thyroid : Official Journal of the American Thyroid Association|January 29, 2015
Molecular testing of thyroid fine-needle aspirations improves presurgical diagnosis and supports the histologic identification of minimally invasive follicular thyroid carcinomasMarkus Eszlinger, Simonetta Piana, Anja Moll, et al.
Pageof 13